Cargando…

miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9

Cisplatin is effective as a single agent or in combination with other drugs for the treatment of non-small cell lung cancer (NSCLC). A concerning clinical challenge with cisplatin-based NSCLC chemotherapy is the intrinsic and acquired chemoresistance to cisplatin. The sterile α motif domain-containi...

Descripción completa

Detalles Bibliográficos
Autores principales:	WU, LIN, PU, XINGXIANG, WANG, QIANZHI, CAO, JUN, XU, FANG, XU, LI, LI, KANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734049/ https://www.ncbi.nlm.nih.gov/pubmed/26893673 http://dx.doi.org/10.3892/ol.2015.4000

Ejemplares similares

Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations
por: Ahmed, Ibrahim A., et al.
Publicado: (2019)

HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96
por: Feng, Jin, et al.
Publicado: (2014)

Evolution and divergence of the mammalian SAMD9/SAMD9L gene family
por: Lemos de Matos, Ana, et al.
Publicado: (2013)

SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies
por: Davidsson, Josef, et al.
Publicado: (2018)

miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression
por: Yu, Nengwang, et al.
Publicado: (2015)

Structure and function of an effector domain in antiviral factors and tumor suppressors SAMD9 and SAMD9L
por: Peng, Shuxia, et al.
Publicado: (2022)

Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma
por: Lin, Meihua, et al.
Publicado: (2018)

Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells
por: Thomas, Melvin E., et al.
Publicado: (2021)

Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring miR-613
por: Li, Delong, et al.
Publicado: (2020)

MiR-7-5p suppresses invasion via downregulation of the autophagy-related gene ATG7 and increases chemoresistance to cisplatin in BCa
por: Wang, Chong, et al.
Publicado: (2022)

Functional Study of SAMD9L in Familial Gastric Cancer
por: Kaixuan, Xu, et al.
Publicado: (2023)

Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes
por: Sahoo, Sushree S., et al.
Publicado: (2020)

SOX2 mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p
por: Cui, Fei, et al.
Publicado: (2020)

miR-451 suppresses the malignant characteristics of colorectal cancer via targeting SAMD4B
por: Wu, Chunrong, et al.
Publicado: (2021)

Ataxia-pancytopenia syndrome with SAMD9L mutations
por: Gorcenco, Sorina, et al.
Publicado: (2017)

The miR-378c-Samd1 circuit promotes phenotypic modulation of vascular smooth muscle cells and foam cells formation in atherosclerosis lesions
por: Tian, Shengya, et al.
Publicado: (2021)

Liver fibrosis-derived exosomal miR-106a-5p facilitates the malignancy by targeting SAMD12 and CADM2 in hepatocellular carcinoma
por: Hu, Juan, et al.
Publicado: (2023)

Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a
por: Lin, Huanxin, et al.
Publicado: (2010)

miR-133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion
por: Zou, Yonggen, et al.
Publicado: (2018)

MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition
por: Cao, Lanqin, et al.
Publicado: (2018)

miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin
por: Chen, Xuesong, et al.
Publicado: (2016)

Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer
por: Li, Ming, et al.
Publicado: (2020)

miR-181b inhibits chemoresistance in cisplatin-resistant H446 small cell lung cancer cells by targeting Bcl-2
por: Liu, Hui-Ning, et al.
Publicado: (2018)

miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer
por: Hong, Yeting, et al.
Publicado: (2016)

MiR‐192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway
por: Li, Yang, et al.
Publicado: (2021)

Emerging phenotypes linked to variants in SAMD9 and MIRAGE syndrome
por: Suntharalingham, Jenifer P., et al.
Publicado: (2022)

MiR-96-5p inhibition induces cell apoptosis in gastric adenocarcinoma
por: Zhou, He-Ying, et al.
Publicado: (2019)

Downregulation of exosomal miR-1273a increases cisplatin resistance of non-small cell lung cancer by upregulating the expression of syndecan binding protein
por: Zhao, Xiaolong, et al.
Publicado: (2020)

MiR-96 enhances cellular proliferation and tumorigenicity of human cervical carcinoma cells through PTPN9
por: Ma, Xiaoping, et al.
Publicado: (2018)

Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy
por: Jiang, Meilin, et al.
Publicado: (2020)

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
por: Zhou, Yong, et al.
Publicado: (2014)

Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition
por: Kirave, Prathibha, et al.
Publicado: (2020)

Germline SAMD9 Mutation in Siblings with Monosomy 7 and Myelodysplastic Syndrome
por: Schwartz, Jason R., et al.
Publicado: (2017)

A familial SAMD9 variant present in pediatric myelodysplastic syndrome
por: Rahim, Mahvish Q., et al.
Publicado: (2023)

Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
por: Wang, De-Ying, et al.
Publicado: (2020)

Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3
por: Fisher, Laura
Publicado: (2021)

MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2
por: Liao, Hongzhan, et al.
Publicado: (2015)

miR-96 promotes invasion and metastasis by targeting GPC3 in non-small cell lung cancer cells
por: Fei, Xiubin, et al.
Publicado: (2018)

SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9‐Mediated GSK3β/β‐Catenin Signaling
por: Li, Qing, et al.
Publicado: (2023)

Horizontal Transfer of miR-643 from Cisplatin-Resistant Cells Confers Chemoresistance to Recipient Drug-Sensitive Cells by Targeting APOL6
por: Raji, Grace R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_39lgn8hjg6hgd6sf92h1jsolfu